Using allogenic preclinical model, we have shown that CD8 T cells from TCF-1 cKO effectively clear tumor cells without inducing GVHD by producing significantly less inflammatory cytokines as proinflammatory cytokines are considered the hallmark of alloimmunity [31]. The gene discussed is CD8A; the disease is graft versus host disease.